Researchers are excited about Retatrutide , a groundbreaking dual agonist showing promising results in initial trials for weight management. It works by impacting several pathways : GLP-1 and GIP, https://caoimhezaqr032177.webbuzzfeed.com/41114945/this-new-possibility-for-weight-reduction